| 英文名称 |
中文名称 |
CAS号 |
操作 |
| GW5074 |
GW5074 |
220904-83-6 |
详细
|
| Erastin |
爱拉斯汀 |
571203-78-6 |
详细
|
| Okadaic acid |
冈田(软海绵)酸 |
78111-17-8 |
详细
|
| VX-702 |
6-[(氨基羰基)(2,6-二氟苯基)氨基]-2-(2,4-二氟苯基)-3-吡啶甲酰胺 |
745833-23-2 |
详细
|
| Foretinib |
N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 |
849217-64-7 |
详细
|
| BKM120 |
BKM120 (PI3K抑制剂) |
1202777-78-3 |
详细
|
| Ammonium phosphate dibasic |
磷酸氢二铵 |
7783-28-0 |
详细
|
| Hygromycin B（50mg/mL） |
潮霉素B（50mg/mL） |
|
详细
|
| CHIR-99021 |
CHIR-99021 (GSK-3抑制剂) |
252917-06-9 |
详细
|
| LY294002 |
LY294002/PI3K抑制剂 |
154447-36-6 |
详细
|
| Ponatinib |
泊那替尼 |
943319-70-8 |
详细
|
| LB-100 |
LB-100 (PP2A抑制剂) |
1026680-07-8 |
详细
|
| Sodium phosphate dibasic dodecahydrate |
磷酸氢二钠,十二水合物,AR,99% |
10039-32-4 |
详细
|
| DAPI Staining Solution |
DAPI染色液 |
28718-90-3 |
详细
|
| Immunostaining Permeabilization Buffer with Triton X-100 |
免疫染色通透液(Triton X-100) |
|
详细
|
| SB203580 |
4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-47-6 |
详细
|
| H-89 |
N-[2-[P-溴苯丙烯盐基氨基]乙基]-5-异喹啉磺酰胺 |
127243-85-0 |
详细
|
| 10%，Ammonium hydroxide solution |
10%，氨水 |
1336-21-6 |
详细
|
| Perifosine |
哌立福辛 |
157716-52-4 |
详细
|
| Dimethyl sulfoxide（≥99.7%,Specialized for cell freezing and storage） |
二甲基亚砜（≥99.7%,细胞冻存专用） |
|
详细
|
| OSU-03012 |
OSU-03012 (PDK-1抑制剂) |
742112-33-0 |
详细
|
| PLX4032 |
维罗非尼 |
1029872-54-5 |
详细
|
| mitochondrial extraction kit |
线粒体提取试剂盒 |
|
详细
|
| Protease and phosphatase inhibitor cocktail for general use, 50X |
蛋白酶磷酸酶抑制剂混合物(通用型 , 50X) |
|
详细
|
| calcium fluorescence probe |
Fluo-4 AM (钙离子荧光探针, 2mM) |
|
详细
|
| Citric acid monohydrate |
柠檬酸,一水合物 |
99-11-6 |
详细
|
| TWS119 |
TWS119 (GSK-3抑制剂) |
601514-19-6 |
详细
|
| N,N-Dimethylformamide |
N，N-二甲基甲酰胺 |
68-12-2 |
详细
|
| BIRB 796 |
多马莫德 |
285983-48-4 |
详细
|
| GDC0941 |
GDC0941 (PI3K抑制剂) |
|
详细
|
| Losmapimod |
Losmapimod (GW856553X) |
585543-15-3 |
详细
|
| CAL-101 |
CAL-101 (PI3K抑制剂) |
870281-82-6 |
详细
|
| PD 98,059 |
2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮 |
167869-21-8 |
详细
|
| Dabrafenib |
达拉菲尼 |
1195765-45-7 |
详细
|
| Triciribine |
Triciribine (Akt抑制剂) |
35943-35-2 |
详细
|
| WH-4-023 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE |
837422-57-8 |
详细
|
| PP2 |
PP2 |
|
详细
|
| GW9662 |
2-氯-5-硝基-N-苯基苯酰胺 |
22978-25-2 |
详细
|
| AZ20 (ATM/ATR inhibitor) |
AZ20 (ATM/ATR抑制剂) |
|
详细
|
| Saracatinib |
塞卡替尼 |
2152628-33-4 |
详细
|
| NU7026 |
NU7026 |
|
详细
|
| Phosphate Buffer(0.2M,pH7.0) |
磷酸缓冲液(0.2M,pH7.0) |
|
详细
|
| SGX-523 |
SGX-523 |
1022150-57-7 |
详细
|
| PP121 |
PP121 |
1092788-83-4 |
详细
|
| Potassium phosphate dibasic trihydrate |
磷酸氢二钾,三水合物 |
16788-57-1 |
详细
|
| 10%，Ammonium hydroxide solution |
10%，氨水（无菌） |
|
详细
|
| Trypsin inhibitor |
胰蛋白酶抑制剂 |
9035-81-8 |
详细
|
| BYL719 |
BYL719 (PI3K抑制剂) |
1217486-61-7 |
详细
|
| Anisomycin |
茴香霉素 |
22862-76-6 |
详细
|
| SB202190 |
4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-30-7 |
详细
|
| AKT inhibitor VIII |
AKT inhibitor VIII (Akt抑制剂) |
|
详细
|
| Urea |
尿素 |
57-13-6 |
详细
|
| SB239063 |
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑 |
193551-21-2 |
详细
|
| Potassium phosphate monobasic |
磷酸二氢钾 |
7778-77-0 |
详细
|
| PBS-EDTA Buffer(Powder) |
PBS-EDTA缓冲液（干粉） |
|
详细
|
| Methoxypolyethylene glycol |
聚乙二醇单甲醚 |
9004-74-4 |
详细
|
| ANA-12 |
ANA-12 |
219766-25-3 |
详细
|
| N'-Nitro-L-arginine methyl ester hydrochloride |
N'-硝基-L-精氨酸甲酯盐酸盐 |
51298-62-5 |
详细
|
| SP600125 |
吡唑蒽酮 |
129-56-6 |
详细
|
| SU6656 |
SU 6656 |
|
详细
|
| IM-12 (GSK-3 inhibitor) |
IM-12 (GSK-3抑制剂) |
|
详细
|
| 2,5-Dimethoxy-2,5-dihydrofuran |
2,5-二甲氧基二氢呋喃,97% |
332-77-4 |
详细
|
| Bosutinib |
博舒替尼 |
380843-75-4 |
详细
|
| invertase |
蔗糖酶 |
|
详细
|
| PI-103 |
PI-103 (PI3K抑制剂) |
|
详细
|
| Ammonium chloride |
氯化铵,99.99% |
12125-02-9 |
详细
|
| PAGE Gel Accelerator (non-TEMED) |
PAGE胶促凝剂（非TEMED） |
|
详细
|
| NA |
匹立尼酸 (PPAR激活剂) |
|
详细
|
| PD169316 |
4-(4-FLUOROPHENYL)-2-(4-NITROPHENYL)-5-(4-PYRIDYL)-1H-IMIDAZOLE |
|
详细
|
| AR-A014418 |
AR-A014418 (GSK-3抑制剂) |
|
详细
|
| Wortmannin |
渥曼青霉素 |
19545-26-7 |
详细
|
| PHA-665752 |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
详细
|
| MK-2206 dihydrochloride |
MK-2206 2HCl (Akt抑制剂) |
1032350-13-2 |
详细
|
| Pilaralisib |
Pilaralisib (PI3K抑制剂) |
934526-89-3 |
详细
|
| Resveratrol |
白藜芦醇 |
501-36-0 |
详细
|
| KT5823 |
蛋白激酶仰制剂KT5823 |
126643-37-6 |
详细
|
| Polyacrylamide |
聚丙烯酰胺(PHIII),阴离子型，1200-1400万分子量 |
9003-05-8 |
详细
|
| New Rapid Plant Genomic DNA Isolation Kit |
新型植物基因组DNA快速提取试剂盒 |
|
详细
|
| Dichloromethane |
二氯甲烷,HPLC级,≥99.9% |
75-09-2 |
详细
|
| Tris-Acetate Buffer(0.2M,pH7.8,RNase-free) |
Tris-乙酸缓冲液(0.2M,pH7.8,无RNase) |
|
详细
|
| 0.25M Calcium chloride |
0.25M 氯化钙(无菌) |
|
详细
|
| Sodium phosphate monobasic dihydrate |
二水合磷酸二氢钠,AR |
13472-35-0 |
详细
|
| Tivantinib |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 |
905854-02-6 |
详细
|
| Soy protein isolate |
大豆分离蛋白 |
9010-10-0 |
详细
|
| Rucaparib |
瑞卡帕布 |
459868-92-9 |
详细
|
| SC79 |
SC79 (Akt激活剂) |
305834-79-1 |
详细
|
| CP21R7 |
CP21R7 (GSK-3β抑制剂) |
125314-13-8 |
详细
|
| PP1 |
蛋白磷酸酯酶-1(抗原) |
172889-26-8 |
详细
|
| Pyridine |
吡啶,Standard for GC,>99.7%(GC) |
110-86-1 |
详细
|
| Universal KGB Buffer(10×) |
通用内切酶缓冲液(10×) |
|
详细
|
| Ethylene imine polymer |
聚乙烯亚胺 |
9002-98-6 |
详细
|
| GSK690693 |
GSK690693 (Akt抑制剂) |
937174-76-0 |
详细
|
| NU-7441 |
8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 |
503468-95-9 |
详细
|
| Sorafenib |
索拉菲尼 |
284461-73-0 |
详细
|
| Chlorotrianisene |
氯烯雌醚 |
569-57-3 |
详细
|
| KU-55933 |
2-(MORPHOLIN-4-YL)-6-(THIANTHREN-1-YL)-4H-PYRAN-4-ONE |
|
详细
|
| Magnesium sulfate |
硫酸镁,七水合物 |
10034-99-8 |
详细
|
| TDZD-8 |
TDZD-8 (GSK-3抑制剂) |
|
详细
|
| 4-Nitrophenyl β-D-glucopyranoside |
4-硝基苯基-β-D-吡喃葡萄糖苷 pNPG |
2492-87-7 |
详细
|
| VX745 |
|
|
详细
|